학술논문
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
Document Type
Article
Author
Source
In Leukemia Research August 2013 37(8):877-882
Subject
Language
ISSN
0145-2126